FRONTERA THERAPEUTICS
Frontera Therapeutics is an AAV gene therapy company with the mission to establish a low-cost and scalable platform, to develop and produce high-quality and affordably priced rAAV therapies for the global market.
FRONTERA THERAPEUTICS
Industry:
Biotechnology
Founded:
2019-09-01
Address:
Bedford, Massachusetts, United States
Country:
United States
Website Url:
http://www.cn.fronteratherapeutics.com
Status:
Active
Contact:
617-546-7300
Email Addresses:
[email protected]
Total Funding:
160 M USD
Investors List
Sequoia Capital China
Sequoia Capital China investment in Series B - Frontera Therapeutics
Loyal Valley Capital
Loyal Valley Capital investment in Series B - Frontera Therapeutics
Zhengxingu Capital
Zhengxingu Capital investment in Series B - Frontera Therapeutics
Creacion Ventures
Creacion Ventures investment in Series B - Frontera Therapeutics
OrbiMed
OrbiMed investment in Series B - Frontera Therapeutics
Boyu Capital
Boyu Capital investment in Series B - Frontera Therapeutics
Starr Investment Holdings LLC
Starr Investment Holdings LLC investment in Series B - Frontera Therapeutics
Official Site Inspections
http://www.cn.fronteratherapeutics.com
- Host name: server-3-167-99-67.iad55.r.cloudfront.net
- IP address: 3.167.99.67
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Frontera Therapeutics"
关于我们_芳拓生物科技(上海)有限公司 - Frontera …
关于我们-芳拓生物科技(上海)有限公司Frontera Therapeutics成立于 2019年9月19日，由国际知名且实力雄厚的风投基金泓元资本和奥博资本投资创立。公司汇聚中美两地具有丰富创新药物研发、临床研究、注册和生产管理经验的专业人 …See details»
About Frontera – Frontera Therapeutics, Inc.
Frontera's state-of-the-art APEX Technology & Manufacturing Platform provides manufacturing with processes that are reliable and scalable, avoiding poor product quality and/or high costs …See details»
Frontera Therapeutics, Inc.
Nov 12, 2024 Frontera's APEX Technology & Manufacturing Platform is an innovative adeno-associated virus (AAV) gene expression system. It includes novel and clinically validated AAV …See details»
Contact Us - Frontera Therapeutics
CN; Contact Us. Boston Office. Research & Development One Patriots Park, Bedford, MA 01730. Phone: 617-546-7300 Email (Corporate or Partnering inquiries): us …See details»
Frontera Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 617-546-7300 Frontera Therapeutics is an AAV gene therapy company with the mission to establish a low-cost and scalable platform, to develop and produce high …See details»
芳拓生物科技(上海)有限公司 - Frontera Therapeutics
AAV载体构建平台 . Frontera公司研发团队采用专有的、优化的载体构建技术平台，基于组织特异性、转导效率、安全性和生产工艺的可扩展性，筛选出最佳AAV衣壳，再通过衣壳和基因表达 …See details»
Frontera Therapeutics - Overview, News & Similar companies
Jul 29, 2023 Frontera Therapeutics Doses First Patient in a Clinical Trial of FT-003 Gene Therapy for the Treatment of Wet AMD BEDFORD, Mass. and SHANGHAI, China, Feb. 02, …See details»
方拓生物 - 公司详情 - 概念题材 - innoHere英诺嘿呀
Frontera Therapeutics创立于2019年9月，汇聚了中美两地具有丰富创新基因药物研发、生产、注册、临床研究管理经验的专业人员，聚焦罕见病及慢性疾病领域，致力于研发和生产高质量的 …See details»
Yong Dai, Ph.D. – Frontera Therapeutics, Inc.
Dr. Yong Dai is a Founder of Frontera Therapeutics. Dr. Dai is a proven leader in biologics and gene therapy drug development. Before joining Frontera, Dr. Dai most recently served as the Chief Technology Officer at Prevail Therapeutics, …See details»
方拓生物科技（苏州）有限公司正式启动产业化基地建设
分类： 公司新闻 作者： 来源： 发布时间： 2021-10-09 14:18 访问量： 【概要描述】 方拓生物科技（苏州）有限公司（Frontera Therapeutics）（以下简称“方拓生物”）产业化基地开工仪式在苏州工业园区生物医药产业园隆重举行。See details»
Frontera Therapeutics, Inc. (Frontera Therapeutics, Inc.) - 药物管 …
了解Frontera Therapeutics, Inc. (Frontera Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的12项临床试验, 274篇新闻，疾病领域:血液及淋巴系统疾病，内分泌与代谢疾 …See details»
芳拓生物科技(上海)有限公司 - Frontera Therapeutics
载体设计和工程化平台. Frontera 技术团队根据特定的AAV靶向组织特点，采用多种方法单独或组合方式设计并构建新型 AAV 基因治疗载体，包括基因替代、基因沉默、基因编辑等。 通过对 …See details»
方拓生物 - 公司详情 - 资讯 - innoHere英诺嘿呀
Frontera Therapeutics创立于2019年9月，汇聚了中美两地具有丰富创新基因药物研发、生产、注册、临床研究管理经验的专业人员，聚焦罕见病及慢性疾病领域，致力于研发和生产高质量的 …See details»
Technology Platform – Frontera Therapeutics, Inc.
APEX Technology & Manufacturing Platform Highlights. Our APEX Technology & Manufacturing Platform is what makes Frontera a leader in gene therapy.. We focus on rapidly transitioning …See details»
方拓生物：基因治疗国内临床已开启，已融资1.95亿美元医药新闻-…
⌈ByDrug医药新闻摘要⌋ 2022-11-29 07:39，细胞基因治疗前沿：迄今为止，已经确定近300个与IRD相关的致病基因，包括视网膜色素上皮65kDa蛋白基因（RPE65）。 此前在2022年8月， …See details»
Frontera Therapeutics announces CDE clearance to initiate clinical ...
Frontera Therapeutics One Patriots Park, Bedford, MA 01730 617-546-7300 [email protected]See details»
重磅！芳拓生物治疗新生血管性年龄相关性黄斑变性（nAMD）的II …
2024年11月11日，芳拓生物宣布其自主研发的用于治疗新生血管性年龄相关性黄斑变性（namd）的重组腺相关病毒（raav）基因治疗产品（产品代号ft-003）获得美国食品药品监督 …See details»
Frontera Therapeutics Initiates Phase II Clinical Trial for FT-001 in ...
Beijing, China, Decemeber 3rd, 2023 – Frontera Therapeutics (Suzhou) Co., Ltd. (hereinafter referred to as Frontera Therapeutics) convened a meeting in Beijing on December 3 to …See details»
方拓生物启动FT-001注射液的II期临床研究
2023年12月3日，方拓生物科技（苏州）有限公司（以下简称“方拓生物”）在北京召开了ft-001 注射液i期临床研究结果总结暨ii期临床研究启动会议，北京协和医院睢瑞芳教授、于伟泓教授、戴 …See details»